Abstract
Daratumumab is a monoclonal antibody that targets CD38. It has on anti-tumor action on the myeloma cell and an immunomodulatory action. For relapsing ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
